Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Continued as: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume 5, 4 Issues, 2005
ISSN: 1875-5917 (Online)
ISSN: 1568-0088 (Print)
This journal supports open access
ISSN: 1875-5917 (Online)
ISSN: 1568-0088 (Print)
This journal supports open access
Contents
Current Drug Targets - Immune, Endocrine & Metabolic Disorders , Volume 3 - Number 4
Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine
, 3(4): 243 - 253Toshimasa Yamauchi, Kazuo Hara, Naoto Kubota, Yasuo Terauchi, Kazuyuki Tobe, Philippe Froguel, Ryozo Nagai and Takashi Kadowaki
DOI: 10.2174/1568005310303040243
Tissue-Specific Glucocorticoid Reactivating Enzyme, 11β-Hydroxysteoid Dehydrogenase Type 1 (11β-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome
, 3(4): 255 - 262Hiroaki Masuzaki and Jeffrey S. Flier
DOI: 10.2174/1568005310303040255
DGAT: Novel Therapeutic Target for Obesity and Type 2 Diabetes Mellitus
, 3(4): 263 - 270Angela Subauste and Charles F. Burant
DOI: 10.2174/1568005310303040263
Stearoyl-CoA Desaturase-1 and the Metabolic Syndrome
, 3(4): 271 - 280Paul Cohen, James M. Ntambi and Jeffrey M. Friedman
DOI: 10.2174/1568005310303040271
SHIP2: An Emerging Target for the Treatment of Type 2 Diabetes Mellitus
, 3(4): 291 - 298James W. Baumgartener
DOI: 10.2174/1568005310303040291
Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity
, 3(4): 299 - 304Shrikrishna Dadke and Jonathan Chernoff
DOI: 10.2174/1568005310303040299
Webmaster Contact: info@benthamscience.net